CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale CEO sold 5,483 shares at $18.18 ($99,691)
- 4 Open-market sale President sold 2,865 shares at $18.18 ($52,091)
- 4 Open-market sale EVP,General Counsel, Secretary sold 894 shares at $18.18 ($16,255)
- 4 Open-market sale EVP, COO, Head of Commercial sold 552 shares at $18.18 ($10,036)
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Principal Accounting Officer sold 1,025 shares at $27.05 ($27,726)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale Principal Accounting Officer sold 359 shares at $23.80 ($8,544)
- 4 Open-market sale EVP, COO, Head of Commercial sold 472 shares at $23.80 ($11,234)
- 4 Open-market sale Chief Financial Officer sold 553 shares at $23.80 ($13,161)
- 4 Open-market sale EVP & General Counsel sold 782 shares at $23.80 ($18,612)
- 4 Open-market sale President sold 1,501 shares at $23.80 ($35,724)
Page 16 of 70 · 1,382 filings